三叶草肽Ⅲ（TFF3）调节肠上皮细胞核转录因子NF-κB及其新的负反馈调节子扭蛋白Twist的机制：TFF3与肿瘤坏死因子作用的比较
|
摘要
目的
核转录因子κB(NF-κB)是调解炎症,免疫等生物过程的中心性核转录因子。它的作用取决于细胞及刺激类型。研究显示细胞外刺激激活的NF-κB,主要受其上游的IKK激酶调控后的IκB降解表达进行调节。激活的NF-κB复合物转入细胞核,与靶基因启动子结合行使其转录调节功能。
最近,增长的事实显示:哺乳类细胞中存在NF-κB激活的负性调节通路网络。例如:NF-κB的激活不仅导致炎症,存活等相关基因合成上调,也进行NF-κB依赖的NF-κB负性调节子合成及再合成。NF-κB的负性调节通路能够保证细胞内信号的瞬时产生以防止未被调控的NF-κB的激活。在体内,通过终止,阻断前炎症因子诱导的NF-κB活性以限制炎症性损伤是至关重要的。
扭蛋白Twist是以螺旋-环式-螺旋为基本结构的转录因子。最近,Sosic等人证明:1) 扭蛋白Twist与转录因子NF-κB相互作用;2) 在体内,扭蛋白Twist是下调核转录因子NF-κB活性的基本调节子;3) 转录因子NF-κB调节扭蛋白Twist表达。所以,扭蛋白是转录因子NF-κB重要的调节蛋白。它在参与NF-κB通路的负性调节及减缓炎症的应答中起到重要的作用。一组研究也显示扭蛋白存在于哺乳类上皮细胞系中,这提示扭蛋白可能参与上皮组织的生理及病理生理调解过程。
三叶草肽(TFF)为细胞外肽家族。最初,它们被发现在胃肠道。
INTRODUCTIONNF - κB is a transcription factor involved in important biological processes in vivo . The physiological roles of NF - κB are both cell type - and stimulus -dependent. Previous investigations have shown that activation of NF - κB by extracellular stimuli is predominantly mediated by a distinctive signal pathway linked to degradation of IκBα. Activated NK - κB complex is translocated into the nucleus and binds to the promoter regions of its targeted genes.In recent times, a growing body of evidence suggests the existence of auto-regulatory loops for a net negative regulation of NK - κB functions in mammalian cells. For example, activation of NK - κB results not only in up - regulation of genes involving inflammation and cell survival but also in synthesizing/re - synthesizing NK - κB - dependent, negative regulators of NK - κB signaling. The negative regulatory loop of NK - κB ensures transient generation of intracellular signaling to prevent uncontrolled - NK - κB activation. It is critical to limit inflammatory injury by terminating and blocking proinflammatory cytokine — induced NK - κB activity in vivo.Twist protein is a basic helix - loop - helix transcription factor. Previously, Sosic et al. have demonstrated that (1) Twist protein interacts with transcription factor NK - κB;(2) Twist is essential for the down - regulation of NK - κB activity in vivo;and (3) NK - κB regulates Twist gene expression. Thus, Twist
protein is a NK - kB associated protein. It plays an important role in the regulation of the negative regulatory loop of NK - kB pathway and the attenuation of inflammatory responses. Recently, Twist has been shown to be present in mouse mammary epithelial cell lines, suggesting that it may be involved in the regulation of physiological or pathophysiological processes in epithelial tissues.The trefoil factor (TFF) family is a group of extracellular peptides that were originally found in the gastrointestinal (GI) tract. These peptides contain distinctive cystine - rich " trefoil" domains and are resistant to proteolytic degradation. Three mammalian TFFs have been identified, namely, pS2 ( TFF1) , SP (TFF2) , and intestinal trefoil factor (ITF or TFF3 ). In contrast to TGF - alpha and EGF, TFFs are expressed rapidly in response to injury. It has been shown that intestinal epithelium is the targeted tissue of TFFs.TFF3 is predominantly expressed in mucous epithelia. A major source for TFF3 is goblet cells of the small and large intestine. Maximal TFF3 expression in the GI tract was observed in the distal portions of the ileum and the colon. Secretion of TFF3 is evoked by certain neurotransmitters and inflammatory mediators. Previous studies demonstrated that TFF3 enhances restitution in intestinal epithelial cells and sustains mucosa integrity. We showed that TFF3 protects epithelial cells against reactive oxygen species induced - injury. However, it is still unknown whether TFF3 modulates inflammatory responses in intestinal epithelial cells. In the present study, we examined (1) how TFF3 activates NK -kB in intestinal epithelial cells;(2) whether Twist protein is expressed in intestinal epithelial cells and regulated by TFF3 and TNF;and (3) whether Twist protein plays a role in modulation of expression of NK - kB - targeted proinflam-matory cytokines such as IL - 8 in intestinal epithelial cells.MATERIALS AND METHODSReagentsAll cell culture media were obtained from GIBCO Invitrogen. Polyclonal
antibodies against Twist , IkBo: , NF - kB p50, and p65 were purchased from Santa Cruz Biotechnology . Anti -phosphotyrosine mAb (clone 4G10) was purchased from Upstate Biotechnology . HRP - conjugated goat anti — rabbit IgG and anti - mouse IgG were obtained from Jackson Immuno Research Laboratories, Inc. mAb against GAPDH was purchased from Abeam, Inc . Chemicals and molecular biology reagents were purchased from Sigma Chemical Company. Reagents for electrophoresis and Western blotting were supplied by Bio - Rad Laboratories . Precasted 4 - 20% iGels were purchased from Gradipore Ltd . Quanti Kine R Human IL - 8 Immunoassay Kit was purchased from R and D Systems . Protease inhibitor cocktail tablets were supplied by Roche Molecular Bio-chemicals . All tissue culture plasticwares were supplied by Costar . U126 and PD98059 (selective inhibitors for ERK kinase) and MG132 ( a potent protea-some inhibitor) were obtained from Biomol . ECL System and [*y - 2P] -ATP were supplied by Amersham Pharmacia Biotech .Preparation of Rat Recombinant TFF3 in YeastRat TFF3 was expressed from Pichia pastoris yeast using a method modified from our previous protocol. The recombinant protein was purified with a FPLC (AKTA FPLC, Amersham Pharmacia Biotech). The purified TFF3 peptide was visualized as a single band with the silver staining technique. Its biological activity was assessed by the cell migration assay using IEC - 18 cells (Zhu et al. , unpublished data).Cell CultureHT - 29 cells ( human intestinal epithelial cell line derived from colonic ad-enocarcinoma) and IEC - 18 cells ( a nontransformed rat intestinal epithelial cell line) were purchased from American Type Culture Collection (Rockville, MD, USA) and cultured under condition required by ATCC.Western blottingExtracted protein were resolved on SDS - PAGE gel along with molecular
weight standards, then transferred onto a nitrocellulose membrane. The membranes containing sample proteins were used for immunodetection of Twist protein. Briefly, blots preincubated with primary antibody against Twist protein (1: 500) , the blot was washed with PBS -T, and then incubated with PBS -T containing 1:10000 diluted HRP - conjugated goat anti - rabbit IgG . Immune complexes on the blot were visualized using the ECL system. Blots were stripped and reprobed with mAb against GAPDH (1:10000) following a standard procedure.ImmunoprecipitationLysate proteins was treated with rabbit anti - IxBa antibodies at 4X. overnight , and the immune complexes were precipitated with protein A/G - Sepha-rose beads. The beads were thoroughly washed, resuspended in SDS sample buffer, and boiled. Then, the proteins were resolved on 4 -20% SDS r PAGE gel, electrotransferred to a nitrocellulose membrane, and probed with mouse anti - phosphotyrosine monoclonal antibody ( 1:1000 ). The blot was then treated with HRP - conjugated goat anti - mouse IgG and finally detected by ECL reagent.Preparation of Nuclear Extracts from CellsCells were lysized with 500 jxl of buffer A, scraped cell off Petri dishes, and incubated at 4^. The nuclei were collected by a brief centrifugation. The supernatant was removed. The nuclear pellet was washed with buffer A, resuspended in 150 |xl of buffer B and incubated for 15 minutes on ice. Following centrifugation at 14,000 x g for 10 minutes at 4X., the supernatant ( nuclear protein fraction) was diluted in 300 ul buffer C and stored at -80t. Protein concentration was measured by the Bradford's method.Electrophoretic Mobility Shift Assay (EMSA) and Supershift AssayThe NF - kB consensus oligonucleotide was labeled by [ -y - 32P] ATP with T4 polynucleotide kinase. Nuclear extracts, 32P - labeled oligonucleotide probe were added to gel shift binding buffer, and the mixture was incubated at RT for
20 min. Electrophoresis was done, dried, and analyzed using a phosphorimaging system. Supershift experiments wereN performed as follows. Nuclear extracts were incubated with 32P - labeled oligonucleotide . 1 /xg of antibody against p50, p65, p52, c - Rel, or RelB subunit of NF - kB was subsequently added, samples were incubated and electrophoresis was performed. To confirm the specificity of NF - kB DNA binding activity, a competitive experiment was done by adding unlabelled oligonucleotide to the reaction mixture.ELISA assay for quantization IL -8 in conditioned mediumThe cells were seeded, and were cultured to reach confluent monolayer . After every groups cells containing different stimulators were incubated in the serum deprived medium for indicated times. Medium was collected and IL - 8 was detected using Quantikine human IL - 8 immunoassay kit (R&D). Standard curves were generated for IL - 8 using the standard provided in the kit and the concentration of IL — 8 in the cell supernatant was determined by interpreting from the appropriate standard curve.Immiinohistochemical stainingRat intestinal tissues were sectioned with a cryostat system, fixed, and air -dried. Slides were hydrated and incubated with 1% BSA. Next, slides were incubated with rabbit pAb against Twist, washed, and incubated with biotinylat-ed goat anti -rabbit IgG. After washing, slides were incubated with FITC -labeled streptavidin, washed, and covered with FTuorSave reagent. Finally, slides were visualized under a fluorescence microscope.siRNA - mediated Twist gene silencingThe siRNA sequences of double stranded siRNA targeting the human Twist mRNA (Gene Bank Accession No: NM_000474) are: TGG GAT CAA ACT GGC CTG CAA and TAA GAA CAC CTT TAG AAA TAA. These sequences were submitted to BLAST search to ensure that only the Twist gene was targeted by the Twist siRNA, and control sequences ( Non - silencing labeled Control siRNA) were not homologous to any known genes. HT29 cells were transfected
using RNAi Human/Mouse Control Kit (Qiagen, Valencia, CA). For transfec-tion, siRNA (1. 9mg/ ml) was transfected with the RNAiFect reagent ( Qiagen, Valencia, CA). Cells were used for designed experiments on the fourth day after transfection.StatisticsData were expressed as means + s. e. m. Analysis of variance and one way analysis of variance (ANOVA) followed by Fisher's protected least significant difference post hoc test were performaced to assess the significant of differences;P < 0.05 was considered significant.RESULTS1. TFF3 activates NK - kB in intestinal epithelial cells in a manner different from TNFHere, we examined the kinetics of TFF3 - induced NK - kB activation, after HT -29 cells were treated with TFF3. EMSA assay showed a low basal level of NK - kB activity in resting intestine cells.To compare the effect of TFF3 and TNF on the degradation of kBa, HT -29 cells were also treated cells with TNF or TFF3 followed by detection of IicBa protein with Western blot. The data suggested that TFF3 induces partial degradation of Ser - 32 and Ser - 36 of IicBa but without induction of its tyrosine phosphorylation in intestinal epithelial cells. The effect is associated with transient activation of p65/p65 homodimer of NK - kB. In contrast to TFF3, TNF induced more degradation of IkBo: and prolonged activation of p50/p65 hert-erodimer of NK - kB in intestinal epithelial cells.2. TFF3 does not induce EL -8 production in intestinal epithelial cellsPersistent activation of NK - kB in intestinal epithelial cells results in up -regulation of several NK - kB targeted proinflammatory cytokines such as IL - 8. As we have shown that TFF3 induces transient activation of NK - kB in intesti-
nal epithelial cells, however, whether transient activation of NK - kB induces inflammatory mediators is not clear. Thereafter, we measured IL - 8 in culture cell medium treated by TFF3 or TNF with ELISA assay. As shown, TNF strongly induced IL - 8 release in HT - 29 cells, whereas TFF - 3 showed no effect. The data indicated that transient activation of NK - kB by TFF3 did not result in IL — 8 production in intestinal epithelial cells.3. Twist is constitutively expressed in intestinal epithelial cells.To determine whether intestinal epithelium expresses Twist, Western blot a-nalysis was performed. Data indicated that Twist protein was present in both HT -29 and IEC -18 cells with skeletal muscle tissue as the positive control. Furthermore , the localization of Twist protein in rat small intestinal tissue was visualized by immunofluorescence microscopy using anti - Twist polyclonal antibody, data showed Twist exists in cytosol of intestinal epithelial cells and some cells in the lamina propria stained with anti - Twist pAb. The data suggests that Twist protein is present in intestinal epithelial cells in vivo.4. Effect of TNF on the expression of Twist protein in intestinal epithelial cells.Recently, Sosic et al demonstrated that Twist plays an important role in the attenuation of inflammation in multiple tissues such as muscles and skin. Our Western blot analysis revealed that in IEC -18 cells and in HT —29 cells suggests that TNF induces the degradation of Twist in intestinal epithelial cells.We found pretreatment of cells with MG132, a potent inhibitor of protesome resulted in blocking the effect of TNF on the expression of Twist protein. This result suggests that TNF - triggered degradation of Twist in intestinal epithelial cells is mediated by proteasome.5. Effect of TFF3 on the expression of Twist protein in intestinal epithelial cells.Previous investigations have demonstrated that TFF3 is up - regulated in intestinal inflammatory conditions such as inflammatory bowel disease. However,
the role of TFF3 in inflammation remains unclear. We first investigated whether TFF3 regulates Twist expression. Our Western blot analysis revealed that TFF3 increased the expression of Twist protein in intestinal epithelial cells. Pretreat-ment of cells with U126 resulted in blocking the effect of TFF3 on expression of Twist protein. In addition, we obtained similar results by using PD98059, another potent ERK inhibitor. Together, these data suggest that ERK kinase mediates this TFF3 action.6. Twist plays a role in blocking EL -8 production in TFF3 -stimulated intestinal epithelial cells.We demonstrated treatment with siRNA for twist resulted in attenuation of Twist protein expression in intestinal epithelial cells. To examine whether Twist protein modulates IL - 8 expression in TFF3 - stimulated cells, HT - 29 cells were transfected with Twist siRNA. Conditioned - medium was then collected for IL - 8 assay. As shown, HT - 29 cells constitutively secrete IL - 8 protein. The basal level of IL - 8 in cells with silenced Twist was not changed compared to the control group, suggesting that constitutive IL - 8 expression in HT - 29 cells is not modulated by Twist protein. In contrast, TFF3 markedly induced IL - 8 secretion in HT - 29 cells with silenced Twist, indicating endogenous Twist protein plays a role in balancing IL - 8 expression during transient NK - kB activation in intestinal epithelial cells by TFF3.DISCUSSIONSA growing body of evidence suggests that transiently activated NK - kB in non - inflammatory states and persistently activated NK - kB during inflammation play different pathophysiological roles in vivo. During the initial phase of inflammation , proinflammatory cytokines and mediators induce prolonged NK - kB activation in various inflammatory cells and endothelium. The activated NK - kB further up - regulates the expression of a number of proinflammatory molecules. Thus, persistent NK - kB activation during the early phase of inflammation amplifies inflammatory response in vivo.
In contrast, transient activation of NK - kB prior to inflammatory stimulation results in the anti -inflammatory response. For example, several investigators have found that pretreatment of rats with LMW - HA induces hepatoprotec-tion against inflammatory insults via transient activation of NK - kB. In the intestine , preconditioning with lipopolysaccharide results in transient activation of NK - kB and induces protective mechanisms against intestinal dysfunction.In the present study, we demonstrated that TFF3 - induced NK - kB activation is a transient event. The transient activation of NK - kB by TFF3 is followed by induction of Twist protein, a new NK - kB associated negative regulatory molecule for NK - kB pathway. Recent studies have shown that Twist interacts with NK - kB. It represses NK - kB activity and attenuates the inflammatory response via suppression of NK — kB activity. We showed that silencing expression of Twist in TFF3 - treated cell results in the induction of IL - 8, a NK - kB regulated proinflammatory cytokine. Thus, TFF3 - induced transient activating NK - kB is associated with strengthening the negative regulatory loop of NK - kB , which inhibits pro - inflammatory cytokine expression in intestinal epithelial cells and protects against inflammation of the GI mucosa.Intestinal epithelial cells play a unique role in the GI inflammation through its ability to release proinflammatory cytokines such as IL - 1 and IL - 8. Previously, we and others have shown that inflammatory mediators induce NK - kB activation in the intestine. The activated NK - kB further up - regulates the expression of a number of proinflammatory molecules. Meanwhile, NK - kB is controlled by a negative control loop. However, it is not clear whether the loop is regulated during the inflammation. Here, we reported for the first time that Twist protein, a novel molecule in the loop, is present in intestinal epithelial cells in vivo. TNF induces markedly degradation of Twist protein in intestinal epithelial cells by a proteasome - dependent mechanism. The effect is associated with TNF — induced NK - kB activity in the cells, which suggests that (1) cytokines regulate the expression of molecules in the loop;and (2) reduction of Twist protein by TNF may result in maintaining NK - kB activity. Persistent ac-
tivation of NK - kB causes prolonged expression of genes including both induction of and activation by NK - kB.Previous studies have shown that TFF3 is expressed in goblet cells and secreted onto intestinal lumen in normal circumstance. It targets intestinal epithelial cells. In contrast to TNF, TFF3 induces up - regulation of Twist in intestinal epithelial cells. Thus, TFF3 probably plays an important role in maintaining Twist protein in intestinal epithelial cells, which may contribute to down - regulation of inflammation in vivo.The physiological function of Twist in intestinal epithelial cells is not clear. Previously, Twist has been found to play an important role in negative regulation of NK — kB in vivo. Thus, we hypothesize that endogenous Twist in intestinal epithelial cells is involved in controlling proinflammatory cytokine expression during inflammation. This hypothesis is further supported by our observation that TFF3 induces IL - 8 production after elimination of Twist protein from intestinal epithelial cells. Furthermore, since TNF induces degradation of Twist in intestinal epithelial cells, which is associated with prolonged NK - kB activation, to prevent cytokine - induced down - regulation of Twist protein may be a novel strategy for blocking inflammation in the GI tract.Previously, we and others have demonstrated that in response to TFF3 stimulation, intestinal epithelial cells release nitric oxide and prostaglandins. TFF3 activates several intracellular molecules such as NK - kB and ERK in intestinal epithelial cells. In the present study, we found that TFF3 enhances Twist protein level in intestinal epithelial cells. We further showed that the selective inhibitor of ERK kinase attenuates the effect of TFF3 on up - regulation of Twist protein, suggesting that TFF3 activates a distinctive signal pathway involved in the modulation of Twist protein. These observations indicate that multiple intracellular regulatory molecules including ERK, IkBo: , Twist, and NK - kB complex may participate to mediate the effect of TFF3. Dissection of the distinctive signal pathway linking these molecules is the subject of our ongoing research.
ConclusionWe found that TFF3 activates intestinal epithelial NK - kB in a mechanism distinctive from TNF. We demonstrated for the first time that intestinal epithelial cells constitutively express Twist protein, a novel negative regulator for NK - kB pathway. We showed that TNF, which induces prolonged NK - kB activation, induces degradation of Twist protein in intestinal epithelial cells. The TNF effect is mediated by the proteasome activity. In contrast, TFF3, which activates NK - kB in a transient event, up — regulates Twist protein in intestinal epithelial cells. The effect of TFF3 is mediated by endogenous ERK activity. In addition, we showed that Twist protein plays an important role in silencing IL - 8 production in NK - kB activated intestinal epithelial cells.Further understanding of these mechanisms will provide new insights into the controlling process involved in activation of NK - kB in inflammation, and may lead to develop a new pharmaceutical strategy to block GI inflammation.
核转录因子κB(NF-κB)是调解炎症,免疫等生物过程的中心性核转录因子。它的作用取决于细胞及刺激类型。研究显示细胞外刺激激活的NF-κB,主要受其上游的IKK激酶调控后的IκB降解表达进行调节。激活的NF-κB复合物转入细胞核,与靶基因启动子结合行使其转录调节功能。
最近,增长的事实显示:哺乳类细胞中存在NF-κB激活的负性调节通路网络。例如:NF-κB的激活不仅导致炎症,存活等相关基因合成上调,也进行NF-κB依赖的NF-κB负性调节子合成及再合成。NF-κB的负性调节通路能够保证细胞内信号的瞬时产生以防止未被调控的NF-κB的激活。在体内,通过终止,阻断前炎症因子诱导的NF-κB活性以限制炎症性损伤是至关重要的。
扭蛋白Twist是以螺旋-环式-螺旋为基本结构的转录因子。最近,Sosic等人证明:1) 扭蛋白Twist与转录因子NF-κB相互作用;2) 在体内,扭蛋白Twist是下调核转录因子NF-κB活性的基本调节子;3) 转录因子NF-κB调节扭蛋白Twist表达。所以,扭蛋白是转录因子NF-κB重要的调节蛋白。它在参与NF-κB通路的负性调节及减缓炎症的应答中起到重要的作用。一组研究也显示扭蛋白存在于哺乳类上皮细胞系中,这提示扭蛋白可能参与上皮组织的生理及病理生理调解过程。
三叶草肽(TFF)为细胞外肽家族。最初,它们被发现在胃肠道。
INTRODUCTIONNF - κB is a transcription factor involved in important biological processes in vivo . The physiological roles of NF - κB are both cell type - and stimulus -dependent. Previous investigations have shown that activation of NF - κB by extracellular stimuli is predominantly mediated by a distinctive signal pathway linked to degradation of IκBα. Activated NK - κB complex is translocated into the nucleus and binds to the promoter regions of its targeted genes.In recent times, a growing body of evidence suggests the existence of auto-regulatory loops for a net negative regulation of NK - κB functions in mammalian cells. For example, activation of NK - κB results not only in up - regulation of genes involving inflammation and cell survival but also in synthesizing/re - synthesizing NK - κB - dependent, negative regulators of NK - κB signaling. The negative regulatory loop of NK - κB ensures transient generation of intracellular signaling to prevent uncontrolled - NK - κB activation. It is critical to limit inflammatory injury by terminating and blocking proinflammatory cytokine — induced NK - κB activity in vivo.Twist protein is a basic helix - loop - helix transcription factor. Previously, Sosic et al. have demonstrated that (1) Twist protein interacts with transcription factor NK - κB;(2) Twist is essential for the down - regulation of NK - κB activity in vivo;and (3) NK - κB regulates Twist gene expression. Thus, Twist
protein is a NK - kB associated protein. It plays an important role in the regulation of the negative regulatory loop of NK - kB pathway and the attenuation of inflammatory responses. Recently, Twist has been shown to be present in mouse mammary epithelial cell lines, suggesting that it may be involved in the regulation of physiological or pathophysiological processes in epithelial tissues.The trefoil factor (TFF) family is a group of extracellular peptides that were originally found in the gastrointestinal (GI) tract. These peptides contain distinctive cystine - rich " trefoil" domains and are resistant to proteolytic degradation. Three mammalian TFFs have been identified, namely, pS2 ( TFF1) , SP (TFF2) , and intestinal trefoil factor (ITF or TFF3 ). In contrast to TGF - alpha and EGF, TFFs are expressed rapidly in response to injury. It has been shown that intestinal epithelium is the targeted tissue of TFFs.TFF3 is predominantly expressed in mucous epithelia. A major source for TFF3 is goblet cells of the small and large intestine. Maximal TFF3 expression in the GI tract was observed in the distal portions of the ileum and the colon. Secretion of TFF3 is evoked by certain neurotransmitters and inflammatory mediators. Previous studies demonstrated that TFF3 enhances restitution in intestinal epithelial cells and sustains mucosa integrity. We showed that TFF3 protects epithelial cells against reactive oxygen species induced - injury. However, it is still unknown whether TFF3 modulates inflammatory responses in intestinal epithelial cells. In the present study, we examined (1) how TFF3 activates NK -kB in intestinal epithelial cells;(2) whether Twist protein is expressed in intestinal epithelial cells and regulated by TFF3 and TNF;and (3) whether Twist protein plays a role in modulation of expression of NK - kB - targeted proinflam-matory cytokines such as IL - 8 in intestinal epithelial cells.MATERIALS AND METHODSReagentsAll cell culture media were obtained from GIBCO Invitrogen. Polyclonal
antibodies against Twist , IkBo: , NF - kB p50, and p65 were purchased from Santa Cruz Biotechnology . Anti -phosphotyrosine mAb (clone 4G10) was purchased from Upstate Biotechnology . HRP - conjugated goat anti — rabbit IgG and anti - mouse IgG were obtained from Jackson Immuno Research Laboratories, Inc. mAb against GAPDH was purchased from Abeam, Inc . Chemicals and molecular biology reagents were purchased from Sigma Chemical Company. Reagents for electrophoresis and Western blotting were supplied by Bio - Rad Laboratories . Precasted 4 - 20% iGels were purchased from Gradipore Ltd . Quanti Kine R Human IL - 8 Immunoassay Kit was purchased from R and D Systems . Protease inhibitor cocktail tablets were supplied by Roche Molecular Bio-chemicals . All tissue culture plasticwares were supplied by Costar . U126 and PD98059 (selective inhibitors for ERK kinase) and MG132 ( a potent protea-some inhibitor) were obtained from Biomol . ECL System and [*y - 2P] -ATP were supplied by Amersham Pharmacia Biotech .Preparation of Rat Recombinant TFF3 in YeastRat TFF3 was expressed from Pichia pastoris yeast using a method modified from our previous protocol. The recombinant protein was purified with a FPLC (AKTA FPLC, Amersham Pharmacia Biotech). The purified TFF3 peptide was visualized as a single band with the silver staining technique. Its biological activity was assessed by the cell migration assay using IEC - 18 cells (Zhu et al. , unpublished data).Cell CultureHT - 29 cells ( human intestinal epithelial cell line derived from colonic ad-enocarcinoma) and IEC - 18 cells ( a nontransformed rat intestinal epithelial cell line) were purchased from American Type Culture Collection (Rockville, MD, USA) and cultured under condition required by ATCC.Western blottingExtracted protein were resolved on SDS - PAGE gel along with molecular
weight standards, then transferred onto a nitrocellulose membrane. The membranes containing sample proteins were used for immunodetection of Twist protein. Briefly, blots preincubated with primary antibody against Twist protein (1: 500) , the blot was washed with PBS -T, and then incubated with PBS -T containing 1:10000 diluted HRP - conjugated goat anti - rabbit IgG . Immune complexes on the blot were visualized using the ECL system. Blots were stripped and reprobed with mAb against GAPDH (1:10000) following a standard procedure.ImmunoprecipitationLysate proteins was treated with rabbit anti - IxBa antibodies at 4X. overnight , and the immune complexes were precipitated with protein A/G - Sepha-rose beads. The beads were thoroughly washed, resuspended in SDS sample buffer, and boiled. Then, the proteins were resolved on 4 -20% SDS r PAGE gel, electrotransferred to a nitrocellulose membrane, and probed with mouse anti - phosphotyrosine monoclonal antibody ( 1:1000 ). The blot was then treated with HRP - conjugated goat anti - mouse IgG and finally detected by ECL reagent.Preparation of Nuclear Extracts from CellsCells were lysized with 500 jxl of buffer A, scraped cell off Petri dishes, and incubated at 4^. The nuclei were collected by a brief centrifugation. The supernatant was removed. The nuclear pellet was washed with buffer A, resuspended in 150 |xl of buffer B and incubated for 15 minutes on ice. Following centrifugation at 14,000 x g for 10 minutes at 4X., the supernatant ( nuclear protein fraction) was diluted in 300 ul buffer C and stored at -80t. Protein concentration was measured by the Bradford's method.Electrophoretic Mobility Shift Assay (EMSA) and Supershift AssayThe NF - kB consensus oligonucleotide was labeled by [ -y - 32P] ATP with T4 polynucleotide kinase. Nuclear extracts, 32P - labeled oligonucleotide probe were added to gel shift binding buffer, and the mixture was incubated at RT for
20 min. Electrophoresis was done, dried, and analyzed using a phosphorimaging system. Supershift experiments wereN performed as follows. Nuclear extracts were incubated with 32P - labeled oligonucleotide . 1 /xg of antibody against p50, p65, p52, c - Rel, or RelB subunit of NF - kB was subsequently added, samples were incubated and electrophoresis was performed. To confirm the specificity of NF - kB DNA binding activity, a competitive experiment was done by adding unlabelled oligonucleotide to the reaction mixture.ELISA assay for quantization IL -8 in conditioned mediumThe cells were seeded, and were cultured to reach confluent monolayer . After every groups cells containing different stimulators were incubated in the serum deprived medium for indicated times. Medium was collected and IL - 8 was detected using Quantikine human IL - 8 immunoassay kit (R&D). Standard curves were generated for IL - 8 using the standard provided in the kit and the concentration of IL — 8 in the cell supernatant was determined by interpreting from the appropriate standard curve.Immiinohistochemical stainingRat intestinal tissues were sectioned with a cryostat system, fixed, and air -dried. Slides were hydrated and incubated with 1% BSA. Next, slides were incubated with rabbit pAb against Twist, washed, and incubated with biotinylat-ed goat anti -rabbit IgG. After washing, slides were incubated with FITC -labeled streptavidin, washed, and covered with FTuorSave reagent. Finally, slides were visualized under a fluorescence microscope.siRNA - mediated Twist gene silencingThe siRNA sequences of double stranded siRNA targeting the human Twist mRNA (Gene Bank Accession No: NM_000474) are: TGG GAT CAA ACT GGC CTG CAA and TAA GAA CAC CTT TAG AAA TAA. These sequences were submitted to BLAST search to ensure that only the Twist gene was targeted by the Twist siRNA, and control sequences ( Non - silencing labeled Control siRNA) were not homologous to any known genes. HT29 cells were transfected
using RNAi Human/Mouse Control Kit (Qiagen, Valencia, CA). For transfec-tion, siRNA (1. 9mg/ ml) was transfected with the RNAiFect reagent ( Qiagen, Valencia, CA). Cells were used for designed experiments on the fourth day after transfection.StatisticsData were expressed as means + s. e. m. Analysis of variance and one way analysis of variance (ANOVA) followed by Fisher's protected least significant difference post hoc test were performaced to assess the significant of differences;P < 0.05 was considered significant.RESULTS1. TFF3 activates NK - kB in intestinal epithelial cells in a manner different from TNFHere, we examined the kinetics of TFF3 - induced NK - kB activation, after HT -29 cells were treated with TFF3. EMSA assay showed a low basal level of NK - kB activity in resting intestine cells.To compare the effect of TFF3 and TNF on the degradation of kBa, HT -29 cells were also treated cells with TNF or TFF3 followed by detection of IicBa protein with Western blot. The data suggested that TFF3 induces partial degradation of Ser - 32 and Ser - 36 of IicBa but without induction of its tyrosine phosphorylation in intestinal epithelial cells. The effect is associated with transient activation of p65/p65 homodimer of NK - kB. In contrast to TFF3, TNF induced more degradation of IkBo: and prolonged activation of p50/p65 hert-erodimer of NK - kB in intestinal epithelial cells.2. TFF3 does not induce EL -8 production in intestinal epithelial cellsPersistent activation of NK - kB in intestinal epithelial cells results in up -regulation of several NK - kB targeted proinflammatory cytokines such as IL - 8. As we have shown that TFF3 induces transient activation of NK - kB in intesti-
nal epithelial cells, however, whether transient activation of NK - kB induces inflammatory mediators is not clear. Thereafter, we measured IL - 8 in culture cell medium treated by TFF3 or TNF with ELISA assay. As shown, TNF strongly induced IL - 8 release in HT - 29 cells, whereas TFF - 3 showed no effect. The data indicated that transient activation of NK - kB by TFF3 did not result in IL — 8 production in intestinal epithelial cells.3. Twist is constitutively expressed in intestinal epithelial cells.To determine whether intestinal epithelium expresses Twist, Western blot a-nalysis was performed. Data indicated that Twist protein was present in both HT -29 and IEC -18 cells with skeletal muscle tissue as the positive control. Furthermore , the localization of Twist protein in rat small intestinal tissue was visualized by immunofluorescence microscopy using anti - Twist polyclonal antibody, data showed Twist exists in cytosol of intestinal epithelial cells and some cells in the lamina propria stained with anti - Twist pAb. The data suggests that Twist protein is present in intestinal epithelial cells in vivo.4. Effect of TNF on the expression of Twist protein in intestinal epithelial cells.Recently, Sosic et al demonstrated that Twist plays an important role in the attenuation of inflammation in multiple tissues such as muscles and skin. Our Western blot analysis revealed that in IEC -18 cells and in HT —29 cells suggests that TNF induces the degradation of Twist in intestinal epithelial cells.We found pretreatment of cells with MG132, a potent inhibitor of protesome resulted in blocking the effect of TNF on the expression of Twist protein. This result suggests that TNF - triggered degradation of Twist in intestinal epithelial cells is mediated by proteasome.5. Effect of TFF3 on the expression of Twist protein in intestinal epithelial cells.Previous investigations have demonstrated that TFF3 is up - regulated in intestinal inflammatory conditions such as inflammatory bowel disease. However,
the role of TFF3 in inflammation remains unclear. We first investigated whether TFF3 regulates Twist expression. Our Western blot analysis revealed that TFF3 increased the expression of Twist protein in intestinal epithelial cells. Pretreat-ment of cells with U126 resulted in blocking the effect of TFF3 on expression of Twist protein. In addition, we obtained similar results by using PD98059, another potent ERK inhibitor. Together, these data suggest that ERK kinase mediates this TFF3 action.6. Twist plays a role in blocking EL -8 production in TFF3 -stimulated intestinal epithelial cells.We demonstrated treatment with siRNA for twist resulted in attenuation of Twist protein expression in intestinal epithelial cells. To examine whether Twist protein modulates IL - 8 expression in TFF3 - stimulated cells, HT - 29 cells were transfected with Twist siRNA. Conditioned - medium was then collected for IL - 8 assay. As shown, HT - 29 cells constitutively secrete IL - 8 protein. The basal level of IL - 8 in cells with silenced Twist was not changed compared to the control group, suggesting that constitutive IL - 8 expression in HT - 29 cells is not modulated by Twist protein. In contrast, TFF3 markedly induced IL - 8 secretion in HT - 29 cells with silenced Twist, indicating endogenous Twist protein plays a role in balancing IL - 8 expression during transient NK - kB activation in intestinal epithelial cells by TFF3.DISCUSSIONSA growing body of evidence suggests that transiently activated NK - kB in non - inflammatory states and persistently activated NK - kB during inflammation play different pathophysiological roles in vivo. During the initial phase of inflammation , proinflammatory cytokines and mediators induce prolonged NK - kB activation in various inflammatory cells and endothelium. The activated NK - kB further up - regulates the expression of a number of proinflammatory molecules. Thus, persistent NK - kB activation during the early phase of inflammation amplifies inflammatory response in vivo.
In contrast, transient activation of NK - kB prior to inflammatory stimulation results in the anti -inflammatory response. For example, several investigators have found that pretreatment of rats with LMW - HA induces hepatoprotec-tion against inflammatory insults via transient activation of NK - kB. In the intestine , preconditioning with lipopolysaccharide results in transient activation of NK - kB and induces protective mechanisms against intestinal dysfunction.In the present study, we demonstrated that TFF3 - induced NK - kB activation is a transient event. The transient activation of NK - kB by TFF3 is followed by induction of Twist protein, a new NK - kB associated negative regulatory molecule for NK - kB pathway. Recent studies have shown that Twist interacts with NK - kB. It represses NK - kB activity and attenuates the inflammatory response via suppression of NK — kB activity. We showed that silencing expression of Twist in TFF3 - treated cell results in the induction of IL - 8, a NK - kB regulated proinflammatory cytokine. Thus, TFF3 - induced transient activating NK - kB is associated with strengthening the negative regulatory loop of NK - kB , which inhibits pro - inflammatory cytokine expression in intestinal epithelial cells and protects against inflammation of the GI mucosa.Intestinal epithelial cells play a unique role in the GI inflammation through its ability to release proinflammatory cytokines such as IL - 1 and IL - 8. Previously, we and others have shown that inflammatory mediators induce NK - kB activation in the intestine. The activated NK - kB further up - regulates the expression of a number of proinflammatory molecules. Meanwhile, NK - kB is controlled by a negative control loop. However, it is not clear whether the loop is regulated during the inflammation. Here, we reported for the first time that Twist protein, a novel molecule in the loop, is present in intestinal epithelial cells in vivo. TNF induces markedly degradation of Twist protein in intestinal epithelial cells by a proteasome - dependent mechanism. The effect is associated with TNF — induced NK - kB activity in the cells, which suggests that (1) cytokines regulate the expression of molecules in the loop;and (2) reduction of Twist protein by TNF may result in maintaining NK - kB activity. Persistent ac-
tivation of NK - kB causes prolonged expression of genes including both induction of and activation by NK - kB.Previous studies have shown that TFF3 is expressed in goblet cells and secreted onto intestinal lumen in normal circumstance. It targets intestinal epithelial cells. In contrast to TNF, TFF3 induces up - regulation of Twist in intestinal epithelial cells. Thus, TFF3 probably plays an important role in maintaining Twist protein in intestinal epithelial cells, which may contribute to down - regulation of inflammation in vivo.The physiological function of Twist in intestinal epithelial cells is not clear. Previously, Twist has been found to play an important role in negative regulation of NK — kB in vivo. Thus, we hypothesize that endogenous Twist in intestinal epithelial cells is involved in controlling proinflammatory cytokine expression during inflammation. This hypothesis is further supported by our observation that TFF3 induces IL - 8 production after elimination of Twist protein from intestinal epithelial cells. Furthermore, since TNF induces degradation of Twist in intestinal epithelial cells, which is associated with prolonged NK - kB activation, to prevent cytokine - induced down - regulation of Twist protein may be a novel strategy for blocking inflammation in the GI tract.Previously, we and others have demonstrated that in response to TFF3 stimulation, intestinal epithelial cells release nitric oxide and prostaglandins. TFF3 activates several intracellular molecules such as NK - kB and ERK in intestinal epithelial cells. In the present study, we found that TFF3 enhances Twist protein level in intestinal epithelial cells. We further showed that the selective inhibitor of ERK kinase attenuates the effect of TFF3 on up - regulation of Twist protein, suggesting that TFF3 activates a distinctive signal pathway involved in the modulation of Twist protein. These observations indicate that multiple intracellular regulatory molecules including ERK, IkBo: , Twist, and NK - kB complex may participate to mediate the effect of TFF3. Dissection of the distinctive signal pathway linking these molecules is the subject of our ongoing research.
ConclusionWe found that TFF3 activates intestinal epithelial NK - kB in a mechanism distinctive from TNF. We demonstrated for the first time that intestinal epithelial cells constitutively express Twist protein, a novel negative regulator for NK - kB pathway. We showed that TNF, which induces prolonged NK - kB activation, induces degradation of Twist protein in intestinal epithelial cells. The TNF effect is mediated by the proteasome activity. In contrast, TFF3, which activates NK - kB in a transient event, up — regulates Twist protein in intestinal epithelial cells. The effect of TFF3 is mediated by endogenous ERK activity. In addition, we showed that Twist protein plays an important role in silencing IL - 8 production in NK - kB activated intestinal epithelial cells.Further understanding of these mechanisms will provide new insights into the controlling process involved in activation of NK - kB in inflammation, and may lead to develop a new pharmaceutical strategy to block GI inflammation.
引文
1. Yamamoto Y and Gaynor RB: Role of the NF - kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 2001;1: 287 -296.
2. Karin M and Lin A: NF - kappaB at the crossroads of life and death. Nat Immunol 2002;3: 221 -227.
3. Brasier AR, Lu M, Hai T, Lu Y, and Boldogh I: NF - kappa B - inducible BCL - 3 expression is an autoregulatory loop controlling nuclear p50/ NF - kappa B1 residence. J Biol Chem 2001;276: 32080 -32093.
4. Sosic D, Richardson JA, Yu K, Ornitz DM, and Olson EN: Twist regulates cytokine gene expression through a negative feedback loop that represses NF - kappaB activity. Cell 2003;112: 169 -180.
5. Arenzana -Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, and Hay RT: Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA - binding and transcriptional activities of NF - kappa B. Mol Cell Biol 1995;15: 2689 -2696.
6. Chiao PJ, Miyamoto S, and Venna IM: Autoregulation of I kappa B alpha activity. Proc Nad Acad Sci U S A 1994;91: 28 -32.
7. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270(5234) : 283 -286.
8. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M. Immuno- suppression by glucocorticoids: inhibition of NF - kappa B activity through induction of I kappa B synthesis. Science 1995;270: 286 -290
9. Sun SC, Ganchi PA, Ballard DW, and Greene WC: NF - kappa B controls expression of inhibitor I kappa B alpha, evidence for an inducible autoregulatory pathway. Science 1993;259: 1912-1915.
10. Laherty CD, Hu HM, Opipari AW, Wang F, and Dixit VM. The Epstein - Barr virus LMPl gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 1992;267: 24157 -24160.
11. Aherty CD, Perkins ND, and Dixit VM. Human T cell leukemia virus type I Tax and phorbol 12 - myristate 13 - acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B. J Biol Chem 1993;268: 5032 -5039.
12. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, and Murphy WJ. Macrophage nitric oxide synthase gene;two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A 1993;90: 9730 -9734.
13. Schmedtje JF Jr. , Ji YS, Liu WL, DuBois RN, and Runge MS. Hypoxia induces cyclooxygenase - 2 via the NF - kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997;272;601 -608.
14. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, and Ma A. Failure to regulate TNF - induced NF - kappaB and cell death responses in A20 - deficient mice. Science 2000;2350 -2354.
15. DAcquisto F, Sautebin L, Iuvone T, Di Rosa M, and Carnuccio R. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor - kappaB activation in J774 macrophages. FEBS Lett 1998;440: 76-80.
16. Conte E, Bonaiuto C, Nesci C, Crimi N, Vancheri C, and Messina A. : Nuclear factor - kappaB activation in human monocytes stimulated with lipopolysaccharide is inhibited by fibroblast conditioned medium and exogenous PGE2. FEBS Lett 1997;400: 315 -318.
17. Carlson DL, White DJ, Maass DL, Nguyen RC, Giroir B, and Horton JW. Ikappa B overexpression in cardiomyocytes prevents NF - kappa B translo-cation and provides cardioprotection in trauma. Am J Physiol 2003;284: H804-H814.
18. Chen ZF and Behringer RR. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995;9: 686 -699.
19. Sosic D and Olson EN. A new twist on twist - modulation of the NF - kappa B pathway. Cell Cycle 2003;2: 76 -78.
20. Howe LR, Watanabe 0, Leonard J, and Brown AM: Twist is up -regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 2003;63: 1906-1913.
21. Sands BE and Podolsky DK: The trefoil peptide family. Annu Rev Physiol 1996;58: 253-273.
22. Thim L: Trefoil peptides: from structure to function. Cell Mol Life Sci 1997;53: 888-903.
23. Wright NA, Hoffmann W, Otto WR, Rio MC, and Thim L. Rolling in the clover;trefoil factor family (TFF) - domain peptides, cell migration and cancer. FEBS Lett 1997;408: 121 -123.
24. Dignass A, Lynch - Devaney K, Kindon H, Thim L, and Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth
factor beta - independent pathway. J Clin Invest 1994;94;376 -383.
25. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, and Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995;175: 405-414.
26. Hoffmann W, Jagla W, and Wiede A: Molecular medicine of TFF - peptides : from gut to brain. Histol Histopathol 2001;16: 319 -334.
27. Matsuoka Y, Pascall JC, and Brown KD. Quantitative analysis reveals differential expression of mucin ( MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine. Biochim Biopiiys Acta 1999;1489: 336-344.
28. Moro F, Levenez F, Durual S, Plaisancie P, Thim L, Giraud AS, and Cuber J. Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon. Regul Pept 2001;101: 35 -41.
29. Podolsky DK. Mechanisms of regulatory peptide action in the gastrointestinal tract;trefoil peptides. J Gastroenterol 2000;35 Suppl 12: 69 -74.
30. Tan XD, Chen Y, Liu Q, Gonzalez - Crussi F, and Liu X. Prostanoids mediate the protective effect of trefoil factor 3 in oxidant - induced intestinal epithelial cell injury: role of cyclooxygenase - 2. J Cell Sci 2000;113;2149 -2155.
31. Chen YH, Lu Y, De Plaen IG, Wang LY, and Tan XD. Transcription factor NF - kappaB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells. Biochem Biophys Res Commun 2000;274: 576 -582.
32. Kindon H, Pothoulakis C, Thim L, Lynch - Devaney K, and Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109;516 -523.
33. Babyatsky MW, deBeaumont M, Thim L, and Podolsky DK. Oral trefoil peptides protect against ethanol - and indomethacin - induced gastric injury in rats. Gastroenterology 1996;110: 489 -497.
34. Tan XD, Liu QP, Hsueh W, Chen YH, Chang H, and Gonzalez - Crussi F. Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production;priming and enhancing effects of mucin. Biochem J 1999;338: 745-751.
35. Zhu YQ, Lu Y, and Tan XD. Monochloramine induces reorganization of nuclear speckles and phosphorylation of SRp30 in human colonic epithelial cells: role of protein kinase C. Am J Physiol Cell Physiol 2003;285;C1294-C1303.
36. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller -Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, and Peyron JF. Tyrosine phosphorylation of I kappa B - alpha activates NF - kappa B without proteolytic degradation of I kappa B - alpha. Cell 1996, 86: 787 -798.
37. Hu X. Proteolytic signaling by TNFalpha: caspase activation and IkappaB degradation. Cytokine 2003;21: 286 -294.
38. Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, and Zuckerman KS. Ubiquitin/proteasome - dependent degradation of D - type cyclins is linked to tumor necrosis factor - induced cell cycle arrest. J Biol Chem 2002;277: 16528 -16537.
39. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, and Podolsky DK. The trefoil gene family are coordinately expressed immediate - early genes: EGF receptor - and MAP kinase - dependent interregulation. J Clin Invest 1999. 103: R31-R38.
40. Olson TS and Ley K;Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283: R7 -28
41. Ajuebor MN and Swain MG. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 2002;105;137 -143.
42. Laskowski I, Pratschke J, Wilhelm MJ, Gasser M, and Tilney NL. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000;5: 29 - 35.
43. Xuan YT, Tang.XL, Banerjee S, Takano H, Li RC, Han H, Qiu Y, Li JJ, and Bolli R. Nuclear factor - kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 1999;84;1095-1109.
44. Zhao TC, Taher MM, Valerie KC, and Kukreja RC. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF - kappaB and iNOS. Circ Res 2001;89: 915 -922.
45. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase - 2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 2002;90: 602 -608.
46. Wolf D, Schumann J, Koerber K, Kiemer AK, Vollmar AM, Sass G, Papadopoulos T, Bang R, Klein SD, Brune B, and Tiegs G. Low - molecular
- weight hyaluronic acid induces nuclear factor - kappaB - dependent resistance against tumor necrosis factor alpha - mediated liver injury in mice. Hepatology 2001;34: 535 -547.
47. Schwarz NT, Engel B, Eskandari MK, Kalff JC, Grandis JR, and Bauer AJ. Lipopolysaccharide preconditioning and cross - tolerance: the induction of protective mechanisms for rat intestinal ileus. Gastroenterology 2002;123:586-598.
48. Tan XD, Sun X, Gonzalez - Crussi FX, Gonzalez — Crussi F, and Hsueh W. PAF and TNF increase the precursor of NF - kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim Biophys Acta 1994;1215: 157 -162.
49. De Plaen IG, Tan XD, Chang H, Qu XW, Liu QP, and Hsueh W. Intestinal NF - kappaB is activated, mainly as p50 homodimers, by platelet - activating factor. Biochim Biophys Acta 1998;1392: 185 -192.
50. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, and Hsueh W. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet - activating factor and tumour necrosis factor. Br J Pharmacol 2000;129: 307 -314.
51. Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, Brenner DA, and Sartor RB. Inhibition of proinflammatory molecule production by adenovirus - mediated expression of a nuclear factor kappaB super - repressor in human intestinal epithelial cells. J Immunol 1998;160;410 -418.
52. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, and Hannon GJ. Twist is a potential oncogene that inhibits apoptosis. Genes Dev 1999;13: 2207 -2217.
53. Taupin DR, Kinoshita K, and Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 2000;97: 799-804.
54. Tan XD, Hsueh W, Chang H, Wei KR, and Gonzalez - Crussi F. Characterization of a putative receptor for intestinal trefoil factor in rat small intestine;identification by in situ binding and ligand blotting. Biochem Biophys Res Commun 1997;237: 673 -677.
55. Chinery R and Cox HM. Immunoprecipitation and characterization of a binding protein specific for the peptide, intestinal trefoil factor. Peptides 1995;16: 749-755.
2. Karin M and Lin A: NF - kappaB at the crossroads of life and death. Nat Immunol 2002;3: 221 -227.
3. Brasier AR, Lu M, Hai T, Lu Y, and Boldogh I: NF - kappa B - inducible BCL - 3 expression is an autoregulatory loop controlling nuclear p50/ NF - kappa B1 residence. J Biol Chem 2001;276: 32080 -32093.
4. Sosic D, Richardson JA, Yu K, Ornitz DM, and Olson EN: Twist regulates cytokine gene expression through a negative feedback loop that represses NF - kappaB activity. Cell 2003;112: 169 -180.
5. Arenzana -Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, and Hay RT: Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA - binding and transcriptional activities of NF - kappa B. Mol Cell Biol 1995;15: 2689 -2696.
6. Chiao PJ, Miyamoto S, and Venna IM: Autoregulation of I kappa B alpha activity. Proc Nad Acad Sci U S A 1994;91: 28 -32.
7. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270(5234) : 283 -286.
8. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M. Immuno- suppression by glucocorticoids: inhibition of NF - kappa B activity through induction of I kappa B synthesis. Science 1995;270: 286 -290
9. Sun SC, Ganchi PA, Ballard DW, and Greene WC: NF - kappa B controls expression of inhibitor I kappa B alpha, evidence for an inducible autoregulatory pathway. Science 1993;259: 1912-1915.
10. Laherty CD, Hu HM, Opipari AW, Wang F, and Dixit VM. The Epstein - Barr virus LMPl gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 1992;267: 24157 -24160.
11. Aherty CD, Perkins ND, and Dixit VM. Human T cell leukemia virus type I Tax and phorbol 12 - myristate 13 - acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B. J Biol Chem 1993;268: 5032 -5039.
12. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, and Murphy WJ. Macrophage nitric oxide synthase gene;two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A 1993;90: 9730 -9734.
13. Schmedtje JF Jr. , Ji YS, Liu WL, DuBois RN, and Runge MS. Hypoxia induces cyclooxygenase - 2 via the NF - kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997;272;601 -608.
14. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, and Ma A. Failure to regulate TNF - induced NF - kappaB and cell death responses in A20 - deficient mice. Science 2000;2350 -2354.
15. DAcquisto F, Sautebin L, Iuvone T, Di Rosa M, and Carnuccio R. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor - kappaB activation in J774 macrophages. FEBS Lett 1998;440: 76-80.
16. Conte E, Bonaiuto C, Nesci C, Crimi N, Vancheri C, and Messina A. : Nuclear factor - kappaB activation in human monocytes stimulated with lipopolysaccharide is inhibited by fibroblast conditioned medium and exogenous PGE2. FEBS Lett 1997;400: 315 -318.
17. Carlson DL, White DJ, Maass DL, Nguyen RC, Giroir B, and Horton JW. Ikappa B overexpression in cardiomyocytes prevents NF - kappa B translo-cation and provides cardioprotection in trauma. Am J Physiol 2003;284: H804-H814.
18. Chen ZF and Behringer RR. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995;9: 686 -699.
19. Sosic D and Olson EN. A new twist on twist - modulation of the NF - kappa B pathway. Cell Cycle 2003;2: 76 -78.
20. Howe LR, Watanabe 0, Leonard J, and Brown AM: Twist is up -regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 2003;63: 1906-1913.
21. Sands BE and Podolsky DK: The trefoil peptide family. Annu Rev Physiol 1996;58: 253-273.
22. Thim L: Trefoil peptides: from structure to function. Cell Mol Life Sci 1997;53: 888-903.
23. Wright NA, Hoffmann W, Otto WR, Rio MC, and Thim L. Rolling in the clover;trefoil factor family (TFF) - domain peptides, cell migration and cancer. FEBS Lett 1997;408: 121 -123.
24. Dignass A, Lynch - Devaney K, Kindon H, Thim L, and Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth
factor beta - independent pathway. J Clin Invest 1994;94;376 -383.
25. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, and Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995;175: 405-414.
26. Hoffmann W, Jagla W, and Wiede A: Molecular medicine of TFF - peptides : from gut to brain. Histol Histopathol 2001;16: 319 -334.
27. Matsuoka Y, Pascall JC, and Brown KD. Quantitative analysis reveals differential expression of mucin ( MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine. Biochim Biopiiys Acta 1999;1489: 336-344.
28. Moro F, Levenez F, Durual S, Plaisancie P, Thim L, Giraud AS, and Cuber J. Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon. Regul Pept 2001;101: 35 -41.
29. Podolsky DK. Mechanisms of regulatory peptide action in the gastrointestinal tract;trefoil peptides. J Gastroenterol 2000;35 Suppl 12: 69 -74.
30. Tan XD, Chen Y, Liu Q, Gonzalez - Crussi F, and Liu X. Prostanoids mediate the protective effect of trefoil factor 3 in oxidant - induced intestinal epithelial cell injury: role of cyclooxygenase - 2. J Cell Sci 2000;113;2149 -2155.
31. Chen YH, Lu Y, De Plaen IG, Wang LY, and Tan XD. Transcription factor NF - kappaB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells. Biochem Biophys Res Commun 2000;274: 576 -582.
32. Kindon H, Pothoulakis C, Thim L, Lynch - Devaney K, and Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109;516 -523.
33. Babyatsky MW, deBeaumont M, Thim L, and Podolsky DK. Oral trefoil peptides protect against ethanol - and indomethacin - induced gastric injury in rats. Gastroenterology 1996;110: 489 -497.
34. Tan XD, Liu QP, Hsueh W, Chen YH, Chang H, and Gonzalez - Crussi F. Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production;priming and enhancing effects of mucin. Biochem J 1999;338: 745-751.
35. Zhu YQ, Lu Y, and Tan XD. Monochloramine induces reorganization of nuclear speckles and phosphorylation of SRp30 in human colonic epithelial cells: role of protein kinase C. Am J Physiol Cell Physiol 2003;285;C1294-C1303.
36. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller -Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, and Peyron JF. Tyrosine phosphorylation of I kappa B - alpha activates NF - kappa B without proteolytic degradation of I kappa B - alpha. Cell 1996, 86: 787 -798.
37. Hu X. Proteolytic signaling by TNFalpha: caspase activation and IkappaB degradation. Cytokine 2003;21: 286 -294.
38. Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, and Zuckerman KS. Ubiquitin/proteasome - dependent degradation of D - type cyclins is linked to tumor necrosis factor - induced cell cycle arrest. J Biol Chem 2002;277: 16528 -16537.
39. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, and Podolsky DK. The trefoil gene family are coordinately expressed immediate - early genes: EGF receptor - and MAP kinase - dependent interregulation. J Clin Invest 1999. 103: R31-R38.
40. Olson TS and Ley K;Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283: R7 -28
41. Ajuebor MN and Swain MG. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 2002;105;137 -143.
42. Laskowski I, Pratschke J, Wilhelm MJ, Gasser M, and Tilney NL. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000;5: 29 - 35.
43. Xuan YT, Tang.XL, Banerjee S, Takano H, Li RC, Han H, Qiu Y, Li JJ, and Bolli R. Nuclear factor - kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 1999;84;1095-1109.
44. Zhao TC, Taher MM, Valerie KC, and Kukreja RC. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF - kappaB and iNOS. Circ Res 2001;89: 915 -922.
45. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase - 2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 2002;90: 602 -608.
46. Wolf D, Schumann J, Koerber K, Kiemer AK, Vollmar AM, Sass G, Papadopoulos T, Bang R, Klein SD, Brune B, and Tiegs G. Low - molecular
- weight hyaluronic acid induces nuclear factor - kappaB - dependent resistance against tumor necrosis factor alpha - mediated liver injury in mice. Hepatology 2001;34: 535 -547.
47. Schwarz NT, Engel B, Eskandari MK, Kalff JC, Grandis JR, and Bauer AJ. Lipopolysaccharide preconditioning and cross - tolerance: the induction of protective mechanisms for rat intestinal ileus. Gastroenterology 2002;123:586-598.
48. Tan XD, Sun X, Gonzalez - Crussi FX, Gonzalez — Crussi F, and Hsueh W. PAF and TNF increase the precursor of NF - kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim Biophys Acta 1994;1215: 157 -162.
49. De Plaen IG, Tan XD, Chang H, Qu XW, Liu QP, and Hsueh W. Intestinal NF - kappaB is activated, mainly as p50 homodimers, by platelet - activating factor. Biochim Biophys Acta 1998;1392: 185 -192.
50. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, and Hsueh W. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet - activating factor and tumour necrosis factor. Br J Pharmacol 2000;129: 307 -314.
51. Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, Brenner DA, and Sartor RB. Inhibition of proinflammatory molecule production by adenovirus - mediated expression of a nuclear factor kappaB super - repressor in human intestinal epithelial cells. J Immunol 1998;160;410 -418.
52. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, and Hannon GJ. Twist is a potential oncogene that inhibits apoptosis. Genes Dev 1999;13: 2207 -2217.
53. Taupin DR, Kinoshita K, and Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 2000;97: 799-804.
54. Tan XD, Hsueh W, Chang H, Wei KR, and Gonzalez - Crussi F. Characterization of a putative receptor for intestinal trefoil factor in rat small intestine;identification by in situ binding and ligand blotting. Biochem Biophys Res Commun 1997;237: 673 -677.
55. Chinery R and Cox HM. Immunoprecipitation and characterization of a binding protein specific for the peptide, intestinal trefoil factor. Peptides 1995;16: 749-755.